 |
市场调查报告书
商品编码
1427209
全球糖尿病设备市场规模、份额、成长分析、类型、分销管道 - 2023-2030 年产业预测Global Diabetes Device Market Size, Share, Growth Analysis, By Type(BGM Device, Insulin Delivery Device), By Distribution Channels(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2023-2030 |
||||||
2022年，全球糖尿病器材市场规模为290.1亿美元，从2023年的314.2亿美元成长到2031年的5.94亿美元，预测期间（2024-2031年）复合年增长率为8.3%。预计将成长至6000万美元。
由于久坐的生活方式和都市化的加快，全球疾病负担正在增加。根据国际糖尿病联盟的数据，年龄在 20 岁至 79 岁之间的约 5.3 亿人被诊断出患有糖尿病。其他健康状况也与此疾病有关，包括中风、心血管疾病、神经病变和感染疾病。随着疾病管理和併发症预防意识的提高，糖尿病医疗设备的发展预计将加速。先进的胰岛素帮浦、笔和其他糖尿病设备创新的推出正在推动对这些产品的需求。领先的製造商专注于技术进步并开发尖端产品，以占领很大一部分市场。
使用自上而下和自下而上的方法来预测和检验糖尿病设备的全球市场规模，并预测其他各个相关子市场的市场规模。用于估计市场规模的调查方法包括以下细节：透过二次研究确定市场的主要企业，并透过初步和二次研究确定每个地区的市场占有率。整个过程包括研究主要企业的年度报告和财务报告，以及广泛的采访，以获取首席执行官、副总裁、董事和营销负责人等行业领导者的关键见解。马苏。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过了考虑、详细研究、初步研究检验和分析，以获得最终的定量和定性资料。
全球糖尿病设备细分市场分析
全球糖尿病设备市场根据类型、分销管道和地区进行细分。按类型划分，市场分为 BGM 设备、胰岛素输送设备和连续血糖监测设备。从市场区隔来看，市场分为医院药局、零售药局、糖尿病诊所、网路药局。按地区划分，市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。
全球糖尿病设备市场的驱动因素
全球范围内糖尿病发生率的上升是推动糖尿病设备市场成长的关键因素。久坐的生活方式、不良的饮食习惯、肥胖和人口老化等因素导致糖尿病发生率上升。随着越来越多的人被诊断出患有糖尿病，对糖尿病设备的需求不断增长，以有效管理和监测他们的糖尿病状况。
定期自我监测血糖值在糖尿病管理中发挥重要作用。可携式、使用者友善型血糖值监测设备的日益普及正在加速患者的接受度。自我血糖监测使个人能够持续追踪血糖值，就胰岛素剂量和用餐选择做出明智的决定，并有效管理糖尿病。
全球糖尿病器材市场的限制因素
糖尿病设备的准确性和可靠性是成功管理糖尿病的基础。然而，根据仪器的不同，测量结果可能会有所不同，可能会出现校准问题或技术故障，进而影响资料的可靠性。不准确的测量可能会导致错误的治疗选择并威胁患者的健康。确保糖尿病设备的准确性和可靠性对于建立医疗保健专业人员和糖尿病管理个人的信任至关重要。
全球糖尿病设备市场趋势
胰岛素帮浦和笔等胰岛素输送系统不断进步，具有更复杂的功能和连接性。市场正在看到智慧胰岛素输送系统的趋势，该系统与连续血糖监测 (CGM) 系统同步，并能够根据血糖读数自动调整胰岛素。此类系统提高了便利性、准确性和客製化的胰岛素输送，以增强血糖控制。
目录
- 执行摘要
- 调查方法
- 母市场分析
- 主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考虑
- 市场动态
- 全球糖尿病设备市场：按类型
- 市场概况
- 背景音乐装置
- 胰岛素给药装置
- 连续血糖监测
- 全球糖尿病设备市场：按分销管道划分
- 市场概况
- 医院药房
- 零售药房
- 糖尿病诊所
- 网路药房
- 全球糖尿病设备市场规模：按地区划分
- 市场概况
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区
- 竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
- 主要企业简介
- Medtronic（United States）
- Roche（Switzerland）
- Johnson & Johnson（United States）
- Abbott Laboratories（United States）
- Becton, Dickinson and Company（United States）
- Novo Nordisk（Denmark）
- Dexcom（United States）
- Sanofi（France）
- Insulet Corporation（United States）
- Ascensia Diabetes Care Holdings AG（Switzerland）
- Ypsomed Holding AG（Switzerland）
- Eli Lilly and Company（United States）
- LifeScan（United States）
- Tandem Diabetes Care（United States）
- Terumo Corporation（Japan）
- Arkray（Japan）
- Senseonics Holdings, Inc.（United States）
- MicroPort Scientific Corporation（China）
- Nipro Corporation（Japan）
- Sinocare Inc.（China）
- AgaMatrix Holdings LLC（United States）
- Trividia Health, Inc.（United States）
Global Diabetes Device Market size was valued at USD 29.01 Billion in 2022 and is poised to grow from USD 31.42 Billion in 2023 to USD 59.46 Billion by 2031, at a CAGR of 8.3% during the forecast period (2024-2031).
The global burden of illness is on the rise due to the adoption of sedentary lifestyles and increasing urbanization. According to the International Diabetes Federation, approximately 530 million individuals aged 20 to 79 have been diagnosed with diabetes. Other health conditions such as stroke, cardiovascular issues, nerve damage, and infections are also linked to this disease. As awareness of disease management and prevention of complications grows, the development of diabetes medical devices is expected to accelerate. The introduction of advanced insulin pumps, pens, and other technological innovations in diabetic devices is fuelling the demand for these products. Leading manufacturers are focusing on technological advancements and the creation of state-of-the-art products to capture a significant portion of the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Diabetes Device Market Segmental Analysis
Global Diabetes Device Market is segmented on the basis of type, distribution channels and region. By type, the market is segmented into BGM device, insulin delivery device, continuous glucose monitoring. By distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, diabetes clinics, online pharmacies. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Diabetes Device Market
The increasing occurrence of diabetes on a global scale is a key factor propelling the growth of the diabetes device market. Factors like sedentary lifestyles, poor dietary patterns, obesity, and an aging populace are among the contributors to the escalating incidence of diabetes. With a rising number of individuals diagnosed with diabetes, there emerges an elevated need for diabetes devices to effectively manage and monitor the condition.
Regular self-monitoring of blood glucose levels plays a vital role in diabetes management. The accessibility of portable and user-friendly blood glucose monitoring devices has spurred higher acceptance among patients. Self-monitoring empowers individuals to consistently track their blood glucose levels, make informed decisions regarding insulin dosage and dietary selections, and effectively manage their diabetes.
Restraints in the Global Diabetes Device Market
The precision and dependability of diabetes devices are fundamental for successful diabetes management. Nevertheless, certain devices may demonstrate disparities in measurements, calibration challenges, or technical malfunctions, which could affect the reliability of data. Inaccurate readings have the potential to result in erroneous treatment choices and jeopardize patient well-being. Guaranteeing the precision and dependability of diabetes devices is vital for establishing confidence among healthcare practitioners and individuals managing diabetes.
Market Trends of the Global Diabetes Device Market
Insulin delivery systems, such as insulin pumps and pens, are continuously advancing with more sophisticated functionalities and connectivity capabilities. There is a trend in the market towards intelligent insulin delivery systems that synchronize with Continuous Glucose Monitoring (CGM) systems, enabling automatic insulin adjustments according to glucose readings. These systems provide increased convenience, accuracy, and tailored insulin delivery, thereby enhancing glycaemic management.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Market Dynamics
- Global Diabetes Device Market by Type
- Market Overview
- BGM Device
- Insulin Delivery Device
- Continuous Glucose Monitoring
- Global Diabetes Device Market by Distribution Channels
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Diabetes Clinics
- Online Pharmacies
- Global Diabetes Device Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dexcom (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Insulet Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeScan (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arkray (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Senseonics Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinocare Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AgaMatrix Holdings LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trividia Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (United States)
日本糖尿病市场报告：2024-2032
儿科糖尿病治疗市场规模、份额、趋势分析报告：按类型、治疗方法、给药途径、通路、地区和细分市场预测，2024-2030年
糖尿病设备市场、占有率、规模、趋势、行业分析报告：依类型、最终用途、通路、地区、细分市场预测，2024-2032年
糖尿病检验计划的全球市场:洞察与预测(～2030年)
全球糖尿病前期市场 2024-2031
全球糖尿病前期市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测
糖尿病酮酸中毒市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按治疗、按地区和竞争的最终用户细分
糖尿病设备市场，按产品、最终用户、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
糖尿病设备市场规模、份额和趋势分析报告：按类型、分销渠道、最终用途、地区、细分市场趋势，2023-2030 年
糖尿病管理上AI:全球市场的展望